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The expansion of the mammalian cerebral cortex is
safeguarded by a concerted balance between ampli-
fication and neuronal differentiation of intermediate
progenitors (IPs). Nonetheless, the molecular con-
trols governing these processes remain unclear. We
found that the scaffold protein Axin is a critical regu-
lator that determines the IP population size and ulti-
mately the number of neurons during neurogenesis
in the developing cerebral cortex. The increase of
the IP pool is mediated by the interaction between
Axin and GSK-3 in the cytoplasmic compartments
of the progenitors. Importantly, as development pro-
ceeds, Axin becomes enriched in the nucleus to
trigger neuronal differentiation via b-catenin activa-
tion. The nuclear localization of Axin and hence the
switch of IPs from proliferative to differentiative sta-
tus are strictly controlled by the Cdk5-dependent
phosphorylation of Axin at Thr485. Our results
demonstrate an important Axin-dependent regula-
tory mechanism in neurogenesis, providing potential
insights into the evolutionary expansion of the cere-
bral cortex.
INTRODUCTION
The architectural and functional integrity of the mammalian
neocortex requires the tight regulation of neuron production,
which is primarily determined by the proliferation and differenti-
ation of neural progenitor cells (NPCs). Perturbation of the prolif-
eration or differentiation process results in either a reduced or
excessive number of neurons, which leads to the formation of
a smaller or larger brain (i.e., microcephaly or macrocephaly,
respectively). In turn, this causes cortical malfunctions such as
mental retardation. Cortical neurons in embryonic mouse brains
are generated in the proliferative zones by two major types of
NPCs: radial glial cells (RGs) (Noctor et al., 2001), and their
transit-amplifying neuronal-committed progenies, intermediate
progenitors (IPs) (Noctor et al., 2004). RGs located in the ventric-
ular zone (VZ) divide asymmetrically to self-renew and give riseto either a neuron or more commonly an IP. The newly generated
IPs migrate to the subventricular zone (SVZ) and divide symmet-
rically to generate pairs of IPs for one to three cycles before
differentiating into neurons (Pontious et al., 2008). Thus, IPs
are regarded as the major source of neurons (Pontious et al.,
2008), and an increase in IPs relative to RGs may contribute to
the expansion of the human cerebral cortex (Martı´nez-Cerden˜o
et al., 2006). Importantly, the processes of IP amplification and
neuronal differentiation require spatial and temporal coordina-
tion to ensure proper neuron generation.
The generation, proliferation, and neuronal differentiation of
IPs are determined by both intrinsic regulators and extrinsic sig-
nals. The sequential expression of specific transcription factors,
i.e., Pax6 / Ngn2/ Tbr2 / NeuroD / Tbr1, is temporally
correlated with the RG-to-IP-to-neuron transition and probably
contributes to the sequential differentiation of neurons (Englund
et al., 2005). Cell-cycle regulation, such as lengthening of the G1
phase and shortening of the S phase, also underlies the sequen-
tial RG-to-IP-to-neuron differentiation (Arai et al., 2011; Calegari
et al., 2005), implying that cell-cycle regulators control IP ampli-
fication and neuronal differentiation. In particular, cyclinD1
and cyclin-dependent kinase 4 (Cdk4) overexpression in RGs
increases the generation and expansion of IPs (Lange et al.,
2009). Notably, extracellular cues including fibroblast growth
factor (FGF), Notch ligands, sonic hedgehog (Shh), Wnt, trans-
forming growth factor b (TGF-b), and retinoic acid (RA) are exten-
sively involved in neurogenesis, probably through the regulation
of transcription factors or cell-cycle regulators. While FGF
(Kang et al., 2009) and Notch (Mizutani et al., 2007) signaling
suppress IP generation, Shh (Komada et al., 2008) signaling
induces IP amplification. Furthermore, signaling cascades acti-
vated by TGF-b (Vogel et al., 2010) and RA (Siegenthaler et al.,
2009) promote neuronal differentiation. Importantly, canonical
Wnt signaling has been suggested to playmultiple roles in neuro-
genesis, including IP suppression (Chenn and Walsh, 2002;
Gulacsi and Anderson, 2008), IP amplification (Kuwahara et al.,
2010; Munji et al., 2011), and neuronal differentiation (Hirabaya-
shi et al., 2004; Munji et al., 2011). Nonetheless, how these
pathways are integrated and coordinated to ensure proper IP
production and neuronal differentiation remains unclear.
Identifying the molecular switch that governs the transition
from the generation/amplification of IPs to neuronal differentia-
tion is critical for understanding mammalian neurogenesis. In
this study, we investigated whether the scaffold protein AxinNeuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc. 665
Figure 1. Axin Regulates the Amplification and Neuronal Differentiation of NPCs
(A–C) Axin expression in the mouse cortex during midneurogenesis is presented. Neocortical sections of E13.5 (A), E14.5 (B), and E15.5 (C) mice were collected
and stained for Axin. TO-PRO3, a dye that labels DNA.
(D–G) The upregulation of endogenous Axin increased neural progenitor generation, resulting in enhanced neuron production. E13.5 mouse embryos were
injected with an Axin stabilizer, XAV939, in utero and received one pulse of EdU labeling 2 hr (D) or 24 hr later (E–G). The embryos were then sacrificed and
analyzed at E15.5 (D) or E17.5 (E–G) by EdU and TO-PRO3 staining as indicated. XAV939 administration increased the number of EdU+ cells in the VZ/SVZ (the
region within the white lines) at E15.5 (D) and the CP at E17.5 (E and F).
(H–K) Enhanced levels of endogenous Axin by XAV939 increased cortical surface area and the thickness of the cortical upper layers at E17.5. Representative
images of cortical sections (H and J), ratio of pial-to-apical surface area (I), and ratio of the thickness of Cux1+ upper layers to the CP (K) are shown. White lines
indicate the length of the pial and ventricular surfaces (H) and the thickness of the Cux1+ upper layer and CP (J). Cux1 is a marker of the upper-layer cortical
neurons.
(legend continued on next page)
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Axin Is a Key Molecular Control of Neurogenesis(Axin1) is the key molecular control. Originally identified as a
tumor suppressor, the multidomain protein Axin is well charac-
terized as a ‘‘master’’ scaffold for various signaling proteins
including Wnt, Notch, RA, TGF-b, p53, and c-Jun N-terminal ki-
nase (JNK)—all of which are known to control neurogenesis (Guo
et al., 2008; Lyu et al., 2003; Mun˜oz-Descalzo et al., 2011; Rui
et al., 2004). Importantly, the disruption of Axin or Axin-like pro-
teins in Xenopus and zebrafish embryos leads to the devel-
opment of small brains (Heisenberg et al., 2001; Yamamoto
et al., 1998), resembling human microcephaly. Furthermore,
the human Axin gene is located on the short arm of chromosome
16 at position 13.3 (16p13.3), where an unidentified recessive
gene that causes microcephaly is located (Brooks et al., 2006;
Kavaslar et al., 2000). These findings prompted us to determine
whether and how Axin regulates embryonic neurogenesis during
brain development.
Here, we show that the level and subcellular localization of
Axin in NPCs determine whether they undergo amplification or
neuronal differentiation. The interaction between cytoplasmic
Axin and GSK-3b is critical for the amplification of the IP
pool, whereas the interaction between Axin and b-catenin in
the nucleus promotes neuronal differentiation. Intriguingly, the
phosphorylation of Axin at Thr485 by Cdk5 shifts the subcellular
localization of Axin from the cytoplasm to nucleus upon NPC
differentiation, thus acting as a molecular switch that causes
IPs to switch from amplification to differentiation.
RESULTS
Increased Axin Enhances Cortical Neuron Production
Axin was strongly expressed in the developing mouse neocortex
from embryonic day 13.5 (E13.5) to E15.5 (Figure S1A available
online). Although Axin expression was prominent in neuron-
residing intermediate zone/cortical plate (IZ/CP), the protein
was also detected in the VZ/SVZ, where NPCs are predomi-
nantly located (Figures 1A–1C), and was expressed in cultured
NPCs (Figure S1B). As a first step to investigate whether Axin
plays an important role in embryonic neurogenesis, we exam-
ined the functional consequence of increasing the endogenous
level of Axin in mouse cortices at E13.5 by in utero intraventric-
ular microinjections of a tankyrase inhibitor, XAV939 (Huang
et al., 2009), which allows the transient stabilization of Axin pro-
tein (Figures S1C and S1D). After injection, Axin levels increased
by 57.3% ± 5.3% at E14.5 and 29.6% ± 3.4% at E15.5 in mouse
cortices (Figure S1D). Intriguingly, XAV939 injection enhanced
the production of newly generated cells at E15.5 (labeled with
5-ethynyl-20-deoxyuridine [EdU]) incorporation at E13.5), with
a greater percentage of EdU+ NPCs in the VZ/SVZ (Figure 1D;(L and M) Precise levels of Axin are critical for proper neurogenesis. In utero ele
shRNA (shAxin), and pCAGI2G-Axin (Axin) was performed (L), and the percentag
(N and O) Axin knockdown and overexpression at E13.5 reduced and increased
IZ/CP of the Control group was set as 100%, and the relative number of GFP+ n
(P–S) Axin regulated NPC amplification and neuronal differentiation in vitro. (P and
were prelabeled with EdU for 1 hr and treated with XAV939 for 24 hr. Tuj1, a neur
whereas overexpression expanded the NPC pool. NPCs were dissociated from
DCX, immature neuronal marker. (Q and S) Quantification of the three types of c
Scale bars, 500 mm (D, E, and H), 100 mm (A–C, F, J, L, and N), and 10 mm (P and
Student’s t test. See also Figure S1.Control, 38.6% ± 3.7%; XAV939, 61.2% ± 4.3%). The enlarged
NPC pool ultimately led to the generation of more upper-layer
cortical neurons (Cux1+; labeled with EdU at E14.5) in the CP
by E17.5 (Figures 1E–1G, S1E, and S1F), possibly at the expense
of deeper-layer neurons (Ctip2+; Figures S1G and S1H). Robust
cortical neuron production contributes to the expansion of
cortical surface, which is critical for the evolutionary enlargement
of the mammalian cerebral cortex (Rakic, 2009). Consistent with
this notion, XAV939-injected brains exhibited greater cortical
surface area (Figures 1H and 1I) and thicker upper cortical layers
(Cux1+; Figures 1J, 1K, and S1I–S1K) than the controls. Collec-
tively, enhanced Axin protein levels expand the neural progenitor
pool, which augments cortical neuron production, leading to
tangential and radial expansion of the cerebral cortex during
development.
To further investigate the functional roles of Axin, we examined
the effects of Axin overexpression or knockdown in the VZ/SVZ
of the mouse cortex using in utero electroporation (Fang et al.,
2011) (Figures S1B and S1L). Axin overexpression increased
the proportion of GFP+ NPCs in the VZ/SVZ at E15.5 (Figures
1L and 1M), further supporting a role of Axin in maintaining/
amplifying NPCs. In contrast, Axin silencing at E13.5 resulted
in a remarkable reduction of GFP+ cells in the VZ/SVZ at E15.5
with a concomitant increase in the proportion of GFP+ cells in
the IZ/CP; this suggests premature depletion of NPCs and pre-
cocious neuronal differentiation (Figures 1L and 1M). Concor-
dantly, Axin knockdown increased the percentage of cells with
enhanced neuron-specific promoter activity (i.e., cells marked
by GFP expression driven by the NeuroD promoter; Figures
S1M and S1N). Premature neuronal differentiation is closely
associated with early cell-cycle exit. Indeed, Axin-depleted cells
underwent premature cell-cycle exit as shown by a significantly
higher proportion of GFP+ EdU+ cells in the VZ/SVZ negative for
the cell proliferation marker, Ki67 (arrows in Figures S1O and
S1P), with no obvious cell death (Figure S1Q). The precocious
or suppressed neuronal differentiation upon Axin knockdown
and overexpression ultimately resulted in reduced and increased
numbers of upper-layer cortical neurons at E18.5, respectively
(Figures 1N, 1O, and S1R). Notably, a significant number of
Axin-overexpressing neurons were stacked in the IZ, suggesting
that Axin has an alternative function in neuronal migration prob-
ably through the regulation of neuronal polarization (Fang et al.,
2011). To further demonstrate that the protein level of Axin is crit-
ical for regulating NPC neurogenesis, we used in vitro pair-cell
analysis to follow the division of NPCs (Figures 1P–1S). Stabiliza-
tion (Figures 1P and 1Q) and overexpression of Axin (Figures 1R
and 1S) both resulted in the amplification of NPCs (Figures 1Q
and 1S), whereas Axin knockdown increased the tendency ofctroporation of E13.5 mouse embryos with pSUPER (Control), pSUPER-Axin
es of GFP+ cells in the VZ/SVZ and IZ/CP at E15.5 were quantified (M).
neuron production by E18.5, respectively. The number of GFP+ neurons in the
eurons in the shAxin or Axin groups was quantified (O).
Q) XAV939 treatment increased neural progenitor amplification. Cultured NPCs
onal marker; Ki67, a mitotic cell marker. (R and S) Loss of Axin depleted NPCs,
the mouse cortex at E14.5 after Axin knockdown or overexpression at E13.5.
ell division: P-P, N-N, and P-N. P, neural progenitor cell; N, neuron.
R). Error bars indicate SEM. ***p < 0.001, **p < 0.01, *p < 0.05 versus Control;
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Figure 2. Increased Axin Levels Enhance IP
Generation and Amplification
(A–H) Increasing endogenous Axin levels
expanded the IP pool without affecting the number
of RGs. (A and B) XAV939 injection at E13.5
increased the number of IPs (Tbr2+) without
affecting the pool of RGs (Pax6+) at E15.5.
(C–H) After XAV939 injection at E13.5 for 2 hr, the
embryos received one pulse of EdU labeling. The
brain sections were then analyzed at E15.5 by EdU
and neural progenitor marker (Pax6 or Tbr2)
staining as indicated. (D and G) High-magnifica-
tion images of the VZ/SVZ. Arrowheads indicate
Tbr2+ EdU+ IPs (D) and Pax6+ EdU+ RGs (G).
(E and H) Analyses of the percentages of Tbr2+
EdU+ IPs or Pax6+ EdU+ RGs over total EdU+ cells.
(I–N) Axin is required for IP production and
amplification. Mouse embryos were electro-
porated with pSUPER (Control), pSUPER-Axin
shRNA (shAxin), or pCAGI2G-Axin (Axin) in utero
at E13.5 (I and J), and the percentages of Tbr2+
GFP+ and Pax6+ GFP+ cells at E15.5 were quan-
tified (M and N). (K and L) High-magnification
images of the VZ/SVZ. Arrowheads indicate Tbr2+
GFP+ IPs (K) and Pax6+ GFP+ RGs (L).
(O–R) Increased Axin level in RGs promoted IP
production in vitro. In vitro pair-cell analyses after
XAV939 treatment (O) and Axin overexpression in
RGs (Q) are shown. (P and R) Quantification of the
three types of cell differentiation (i.e., RG-RG,
IP-IP, RG-IP).
Scale bars, 500 mm (A and B), 100 mm (C, F, I, and
J), 20 mm (D, G, K, and L), and 10 mm (O and Q).
Error bars indicate SEM. ***p < 0.001, **p < 0.01,
*p < 0.05 versus Control; Student’s t test. ns, not
significant. See also Figure S2.
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Axin Is a Key Molecular Control of NeurogenesisNPCs to divide and differentiate into two neurons (Figure 1S).
Thus, the regulation of Axin protein levels in NPCs at midneuro-
genesis is critical for generating the proper number of neurons
during brain development, probably through the control of
NPC amplification and neuronal differentiation.
Cytoplasmic Axin Promotes the Amplification of IPs
There are two major cell types of NPCs: RGs and IPs. Although
RGs are predominantly found in the mouse cortex for maintain-
ing the NPC pools, IPs are transient, amplifying neurogenic668 Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc.progenitors that contribute to cortical
neuron production. Intriguingly, although
the number of Pax6+ RGs in the cortex
of XAV939-injected embryos was not
substantially different from that of the
controls at E15.5 (Figure 2A), there were
more Tbr2+ IPs in the XAV939-injected
brains than the controls (Figure 2B).
Given that XAV939 administration did
not inhibit neuronal differentiation (Fig-
ures 1E–1G) or affect cell survival (data
not shown), the increased number of IPs
may be due to enhanced IP generation.
Therefore, we labeled mitotic RGs withEdU 2 hr after XAV939 injection and traced the fates of their
progenies at E15.5. XAV939-injected brains exhibited a mark-
edly increased proportion of Tbr2+ EdU+ IPs (Figures 2C–2E),
whereas the Pax6+ EdU+RGpool remained relatively unchanged
(Figures 2F–2H); this suggests that Axin upregulation enhances
IP generation. Consistent with this finding, Axin overexpression
at E13.5 resulted in a significant increase in the IP population
(Figures 2I, 2K, and 2M) without affecting the RG pool at E15.5
(Figures 2J, 2L, and 2N). The expansion of IPs may be attrib-
utable to either increased proliferation of IPs or enhanced
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Axin Is a Key Molecular Control of Neurogenesisdifferentiation from RGs. The proportion of mitotic IPs (pH3+
Tbr2+) remained relatively unchanged when Axin was stabilized
or overexpressed (Figures S2A–S2H), suggesting that Axin
does not markedly affect IP proliferation. Furthermore, Axin
overexpression at E12.5 led to an enlarged IP pool and concom-
itantly a reduced number of deeper-layer neurons (Figures
S2I–S2O); this indicates that Axin expression causes a shift of
neuronal differentiation from RGs toward IP generation. Collec-
tively, Axin upregulation in midneurogenesis enhances IP ampli-
fication, which contributes to increased upper-layer neuron
production (Cux1+; Figures 1E–1K). In addition, consistent with
the observation that Axin knockdown resulted in premature
neuronal differentiation (Figures 1L and 1M), shAxin-electropo-
rated brains exhibited significant reductions in the populations
of both RGs and IPs (Figures 2I–2N), suggesting that Axin is
required for the maintenance/amplification of RGs and IPs.
Furthermore, in vitro pair-cell analysis revealed that both sta-
bilization (Figures 2O and 2P) and overexpression of Axin (Fig-
ures 2Q and 2R) in RGs increased the number of IP-IP progeny
pairs, supporting a role of Axin in facilitating IP generation and
amplification.
Nuclear Accumulation of Axin Switches IP Amplification
to Differentiation
Next, we investigated how increased Axin levels enhance IP
generation. Axin was mainly localized to the cytoplasm of
NPCs in the VZ/SVZ at E13.5 (Figure 3A), whereas the protein
was gradually enriched in the nuclei of a subset of NPCs
(E13.5–E15.5, Figures 3A and S3A–S3C). Therefore, we hypoth-
esized that the subcellular localization of Axin is regulated
differently in different types of NPCs. To further characterize
the subcellular localization of Axin in NPCs, cultured NPCs
were prepared from embryonic mouse cortices and stained
for Axin. Although Axin was predominantly expressed in the
cytoplasm (83.2% ± 6.8% of total Axin) and was weakly detect-
able in the nuclei (16.8% ± 3.3% of total Axin) of RGs (nestin+),
the protein became more enriched in the nuclei of Tbr2+ IPs
(53.3% ± 3.1% of total Axin; Figure 3B). Furthermore, when
NPCs were cultured in neuronal differentiation medium for
3 hr, Axin level increased significantly in the nucleus (3.8 ±
0.7-fold) and decreased significantly in the cytoplasm (by
60.4% ± 6.2%) in differentiating NPCs (Figure 3C). Therefore,
these findings indicate that Axin accumulates in the nuclei of
NPCs in response to differentiation signals.
The nucleocytoplasmic shuttling of Axin is tightly controlled by
the nuclear localization signal (NLS) and nuclear export signal
(NES) of the protein (Cong and Varmus, 2004). To elucidate the
specific roles of cytoplasmic and nuclear Axin, we generated
two point mutants of Axin, allowing the protein to be expressed
specifically in the cytoplasm (Axin-NLSm) or nucleus (Axin-
NESm) (Figure 3D). Like wild-type Axin, the overexpression of
cytoplasmic Axin (Axin-NLSm) at E13.5 increased the proportion
of GFP+ cells in the VZ/SVZ at E15.5 (Figures 3E and 3F), sug-
gesting that cytoplasmic Axin enhances NPC expansion.
Furthermore, the re-expression of Axin-NLSm in Axin-knock-
down NPCs also led to NPC pool expansion (Figures 3G–3L)
specifically through the enlargement of the IP population (Fig-
ures 3H, 3J, and 3L). In contrast, the expression of nuclearAxin (Axin-NESm) (Figures 3E and 3F) or re-expression of the
protein in Axin-knockdown NPCs depleted the GFP+ NPCs in
the VZ/SVZ and promoted the differentiation of NPCs into neu-
rons (Figures 3G–3L). Together with the nuclear accumulation
of Axin in cultured NPCs upon differentiation (Figures 3A–3C),
these findings strongly suggest that Axin in different subcellular
compartments of NPCs specifically regulates the amplification
and differentiation of NPCs; cytoplasmic Axin in RGs enhances
IP amplification, whereas Axin in the nucleus of IPs promotes
neuronal differentiation of IPs.
Phosphorylation-Dependent Subcellular Localization
of Axin Controls Neurogenesis
Next, we investigated themolecular mechanism that controls the
trafficking of Axin between the cytoplasm and nucleus. Treating
RGs with leptomycin B led to the nuclear accumulation of Axin
(Cong and Varmus, 2004) (Figure S4A), suggesting that the
nuclear enrichment of Axin is regulated by nuclear export. It
was noted that the Cdk5-dependent phosphorylation site
(Thr485) is located close to the NES of Axin (amino acids 413–
423) (Fang et al., 2011) (Figure 4A). Although Axin phosphoryla-
tion at Thr485 (p-Axin) could be detected in wild-type mouse
neocortices at E13.5, this specific phosphorylation was mark-
edly reduced in cdk5/ littermates (by 45.5% ± 4.3%; Figures
4B, S4B, and S4C), indicating that Cdk5 is a major kinase that
phosphorylates Axin during neurogenesis in vivo. Importantly,
the nuclear level of Axin was reduced in cdk5/ neocortices
(by 68.2% ± 5.1%) accompanied by an increased level of cyto-
plasmic Axin (2.0 ± 0.3-fold; Figure 4B). These results suggest
that Cdk5-dependent Axin phosphorylation is critical for control-
ling the nuclear localization of Axin in the embryonic cerebral
cortex.
To explore the role of Cdk5-mediated Axin phosphorylation,
we examined how Axin phosphorylation is regulated in NPCs.
Although basal levels of p-Axin were detected in the nuclear
compartments of cultured NPCs, protein phosphorylation was
markedly upregulated upon neuronal differentiation (by 2.1 ±
0.3-fold; Figure 4C). Furthermore, in the developing cortex,
p-Axin was prominently detected in the nuclei of a subset of
NPCs, primarily the IPs (arrowheads in Figures 4D, S4E, and
S4F). The proportion of p-Axin+ NPCs increased progressively
from E13.5 to E15.5 (Figure 4E), and p-Axin was found in the
VZ/SVZ of the mouse neocortex at a rostrolateral-high to caudo-
medial-low gradient (Figures S4G–S4N)—a spatial profile similar
to the gradient of neurogenesis (Caviness et al., 2009). These
observations suggest that increased phosphorylation of Axin at
Thr485 is associated with neurogenesis. Notably, the mitotic
RGs lining the ventricular surface of the VZ were prominently
labeled with p-Axin (Figure S4D); this phosphorylation was not
substantially reduced in cdk5/ cortices (Figure S4C), indi-
cating that Axin phosphorylation in these mitotic cells is likely
mediated by other kinase(s). Importantly, cdk5 knockout (Fig-
ure 4F) or blockade of Cdk5 activity by the overexpression of
the dominant-negative Cdk5 mutant (Cdk5-DN) resulted in an
expansion of the IP pool at E15.5 (Figures 4G–4J); this further
supports a role of Cdk5 in the regulation of neuronal differentia-
tion of IPs, probably through phosphorylation and hence the
nuclear localization of Axin.Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc. 669
Figure 3. The Translocation of Axin from the Cytoplasm to the Nucleus in NPCs Regulates the Shift from IP Amplification to Neuronal
Differentiation
(A) Axin accumulated in the nuclei of NPCs upon development. The proportion of NPCs with nuclear expression of Axin (arrowheads) increased progressively
from E13.5 to E15.5.
(B) Axin staining in cultured NPCs (RGs, nestin+; IPs, Tbr2+) is shown.
(C) Axin was upregulated in the nuclei of cultured NPCs upon neuronal differentiation. PM, proliferation medium; DM, neuronal differentiation medium. Note that
the level of NeuroD1, a proneural protein, was upregulated in NPCs upon DM stimulation. a-Tubulin (tub) served as a cytoplasmic marker and loading control.
(D–F) Cytoplasmic Axin amplified the NPC pool, whereas nuclear Axin promoted neuronal differentiation. (D) Subcellular distribution of Axin and its point mutants
(Axin-NESm and Axin-NLSm) in HEK293T cells is shown. (E and F) E13.5 mouse embryos were electroporated with Axin mutants (Axin-NLSm, cytoplasmic Axin;
or Axin-NESm, nuclear Axin) in utero and examined at E15.5. Distribution of GFP+ cells (F).
(G–L) Cytoplasmic Axin amplified the IP pool. In utero electroporation of shAxin together with the shRNA-resistant Axin-WT and its mutants (NLSm and NESm) is
shown. (I and J) High-magnification images of the VZ/SVZ. Arrowheads indicate GFP+ Pax6+ RGs (I) andGFP+ Tbr2+ IPs (J). Analyses of the percentages of Pax6+
GFP+ RGs (K) and Tbr2+ GFP+ IPs over total GFP+ cells (L) are presented.
Scale bars, 100 mm (E, G, and H), 20 mm (I and J), and 10 mm (A and B). Error bars indicate SEM. ***p < 0.001, **p < 0.01 versus Control (F) and shAxin+AxinRes-WT
(K and L); Student’s t test. See also Figure S3.
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Axin Is a Key Molecular Control of NeurogenesisNext, we investigated the role of the Cdk5-dependent Axin
phosphorylation in neuronal differentiation by examining the
effects of overexpressing phospho-mimetic (Axin-TE) and
phospho-deficient Axin (Axin-TA) mutants in NPCs. Axin-TE670 Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc.mutant was concentrated in the nucleus, whereas Axin-TA
mutant was exclusively detected in the cytoplasm (Figure 5A).
Re-expression of the Axin-TE mutant in Axin-knockdown
cortices promoted the neuronal differentiation of NPCs.
Figure 4. Cdk5-Dependent Axin Phosphorylation Regulates Neurogenesis
(A) Schematic representation of Axin protein.
(B) The phosphorylation of Axin by Cdk5 is critical for the nuclear localization of Axin. Cytoplasmic and nuclear fractions of forebrains from E13.5 cdk5/ mice
and wild-type littermates were subjected to western blot analysis for Axin and Axin phosphorylated at Thr485 (p-Axin).
(C) The p-Axin protein accumulated in the nuclear fraction of cultured NPCs upon neuronal differentiation. a-Tubulin served as a cytoplasmic marker and loading
control.
(D) The p-Axin protein was mainly concentrated in the nuclei of IPs. The majority of p-Axin+ NPCs were Tbr2+ IPs (nuclei were labeled with TO-PRO3).
(E) The expression of p-Axin increased progressively in the nuclei of NPCs in the VZ/SVZ from E13.5 to E15.5.
(F–J) Blockade of Cdk5 activity resulted in IP expansion at E15.5. (F) cdk5/mice exhibited a wider and much more densely packed band of IPs at E15.5. (G–J)
Overexpression of a Cdk5 dominant-negative mutant (Cdk5-DN) inhibited neuronal differentiation (G and H) and increased the number of IPs (I and J).
High-magnification images show the costaining of GFP and Tbr2 (arrowheads in I).
Scale bars, 200 mm (F, upper panels), 100 mm (F, lower panels; G), and 20 mm (D, E, and I). Error bars indicate SEM. **p < 0.01, *p < 0.05 versus Control; Student’s
t test. See also Figure S4.
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Axin Is a Key Molecular Control of NeurogenesisMeanwhile, Axin-TA mutant inhibited neuronal differentiation
and led to the amplification of NPCs (Figures 5B and 5C), mainly
IPs (Figures 5D–5I). Furthermore, the impaired neurogenesis
due to Cdk5-DN expression was partially rescued by the
coelectroporation of either the Axin-TE or Axin-NESm mutant
(Figures 4G–4J and S5A–S5D). These findings provide further
evidence that Cdk5-dependent Axin phosphorylation and
hence the phosphorylation-dependent nuclear localization of
the protein are critical for promoting neuronal differentiation.
To further investigate how p-Axin regulates the neuronal differ-
entiation of IPs, we examined the regulation of p-Axin in IPs with
respect to cell-cycle progression. The S phase cells in devel-
oping mouse brains were pulse labeled with EdU. The EdU-labeled cells in the upper VZ and lower SVZ were in the
S and G2 phases within the first 0.5 and 2 hr after EdU injection,
respectively, and required 14 hr to reach the late G1 phase
(Britz et al., 2006). p-Axin was concentrated in the nuclei of
most progenies of the EdU-labeled cells at the G1 phase
(80.1% ± 8.9%; Figure 5J) but was barely detected in the
EdU+ cells in the S or G2 phases (13.4% ± 4.1%; Figure 5K).
The observation that most p-Axin+ cells in the upper VZ and
lower SVZ were IPs (Figure 4D) suggests that p-Axin+ IPs exit
cell cycling at the G1 phase (Dehay and Kennedy, 2007). There-
fore, we conclude that the Cdk5-dependent phosphorylation of
Axin at Thr485 maintains the nuclear accumulation of Axin in IPs
and promotes neuronal differentiation.Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc. 671
Figure 5. The Phosphorylation of Axin at Thr485 Is Required for the Neuronal Differentiation of IPs
(A) Subcellular distribution of Axin-WT and its mutants (TE, a phospho-mimetic mutant; TA, a phospho-deficient mutant) in HEK293T cells is shown.
(B–I) The phosphorylation of Axin at Thr485 promotes neuronal differentiation. Mouse embryos at E13.5 were electroporated with shAxin together with shRNA-
resistant Axin-WT, Axin-TE, or Axin-TA. (B and C) Re-expression of Axin-TE in Axin-knockdown cortices increased the percentage of GFP+ cells in the IZ/CP,
whereas Axin-TAmutant enhanced the percentage of GFP+ cells in the VZ/SVZ. (D–G) Images of fluorescent staining for Pax6 and Tbr2 are shown. (F andG) High-
magnification images of the VZ/SVZ are presented. Arrowheads indicate Pax6+ GFP+ RGs (F) and Tbr2+GFP+ IPs (G). Analyses of the percentages of Pax6+ GFP+
RGs (H) and Tbr2+ GFP+ IPs (I) over total GFP+ cells are shown.
(J and K) The p-Axin protein accumulated in the nuclei of IPs at the G1 phase, but not at the S or G2 phase. Pregnant mice at day 15.5 of gestation were
intraperitoneally injectedwith EdU, and newborn cells in the embryonic brains at different cell-cycle phaseswere identified by their positive labeling with EdU after
discrete time periods. In the upper VZ and lower SVZ (boxed area), p-Axin protein was detected in the nuclei of the majority (80%) of EdU+ cells in the G1 phase
(J) but barely found in the nuclei of cells in the S and G2 phases (K). Arrowheads (J) and arrows (K) indicate EdU+ cells with or without nuclear p-Axin, respectively.
Scale bars, 100 mm (B, D, and E), 50 mm (J and K, right panels), and 20 mm (F and G; J and K, left panels). Error bars indicate SEM. ***p < 0.001, **p < 0.01, *p < 0.05
versus shAxin+AxinRes-WT; Student’s t test. See also Figure S5.
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Figure 6. Cytoplasmic Axin Promotes IP Amplification via a Mechanism Dependent on Its Interaction with GSK-3b
(A) Axin and GSK-3b were highly expressed and colocalized in the cytoplasm of NPCs in the VZ.
(B) Axin interacted with GSK-3b in the cytoplasmic fraction of cultured NPCs from E13.5 brains.
(C–F) The binding of cytoplasmic Axin to GSK-3b is required to maintain and expand the NPC pool. E13.5 mouse embryos were electroporated in utero with
constructs as indicated and analyzed at E15.5. GIDm, the Axin point mutant that cannot interact withGSK-3b; NLSm, the Axinmutant expressed exclusively in the
cytoplasm. (D and F) Quantification of the distribution of GFP+ cells is shown.
(G–J) Modulating the interaction between Axin andGSK-3b by small peptides regulated the amplification of the NPC pool (G and H) and the generation of IPs from
RGs (I and J). FRATtide, a peptide that enhanced Axin-GSK-3b interaction; GID, a peptide that abolished Axin-GSK-3b interaction. The expressions of small
peptides were driven by a constitutive promoter (pCAGI2G; G) or the radial glia-specific promoter (pGLAST; I).
Scale bars, 100 mm (C, E, G, and I) and 10 mm (A). Error bars indicate SEM. ***p < 0.001, **p < 0.01, *p < 0.05 versus shAxin+AxinRes-WT (D and F) or Control
(H and J); Student’s t test. See also Figure S6.
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Howdoes cytoplasmic Axin amplify IPs? The size of the IP pool is
negatively regulated by multiple pathways including Wnt (Munji
et al., 2011), Notch (Mizutani et al., 2007), and FGF (Kang
et al., 2009) signaling; each of these pathways can bemodulated
by a key regulator, GSK-3 (Kim et al., 2009b). Axin colocalized
and interacted with GSK-3b in the cytoplasmic compartment
of NPCs at E13.5 (Figures 6A, 6B, and S6A). Notably, the re-
expression of an Axin point mutant that failed to bind GSK-3b
(GIDm) (Fang et al., 2011) in Axin-knockdown cortices abolished
the ability of cytoplasmic Axin to enhance NPC amplification,
resulting in early neuronal differentiation (Figures 6C–6F, S6B,and S6C). Therefore, our findings suggest that cytoplasmic
Axin expands the NPC (i.e., IP) population in a GSK-3b-depen-
dent manner. To confirm this finding, we utilized small peptides,
FRATtide (Bax et al., 2001) and GID peptide (Hedgepeth et al.,
1997), which can enhance and block Axin-GSK-3b interaction,
respectively (Figures S6D and S6E), and examined their effects
on the regulation of the fate of NPCs. FRATtide expression led
to the enlargement of the NPC pool (Figures 6G and 6H) and pro-
moted the generation of IPs from RGs (Figures 6I, 6J, S6F, and
S6G); meanwhile, GID peptide depleted the NPC pool (Figures
6G–6H) and promoted the direct neuronal differentiation of
RGs (Figures 6G–6J, S6F, and S6G). Thus, Axin in the cytoplasmNeuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc. 673
Figure 7. Nuclear Axin Enhances Neuronal Differentiation via Binding to b-Catenin
(A) Protein levels of Axin and b-catenin and their interaction were markedly increased in the nuclei of cultured NPCs upon neuronal differentiation.
(B and C) Nuclear interaction between Axin and b-catenin enhanced the transcriptional activity of b-catenin. E13.5 mouse embryos were electroporated with the
TOP-dGFP/mCherry construct together with various plasmids (as indicated) in utero and examined at E15. The transcriptional activity of b-catenin wasmonitored
by the expression of a destabilized GFP driven by the b-catenin-responsive element, TOP-dGFP (B), and the ratio of the number of GFP+ mCherry+ cells
(arrowheads) to the number of mCherry+ cells was quantified (the ratio of the shAxin+AxinRes-WT group was set as 1; C). arb. unit, arbitrary unit.
(D) Overexpression of nuclear Axin in cultured NPCs increased the expression of b-catenin proneural target proteins (Ngn1 and NeuroD1).
(E and F) Nuclear interaction between Axin and b-catenin was required for neuronal differentiation. (E) CIDm, the Axin point mutant unable to bind to b-catenin;
NESm, the Axin mutant whose expression was confined to the nucleus. (F) Quantification of the distribution of GFP+ cells is shown.
(G and H) Blockade of the nuclear interaction between Axin and b-catenin by a nuclear-targeting CID peptide, CID-NLS, inhibited neuronal differentiation.
Scale bars, 100 mm (E and G) and 50 mm (B). Error bars indicate SEM. **p < 0.01, *p < 0.05 versus shAxin+AxinRes-WT (C and F) or Control (H); ##p < 0.01 versus
shAxin+AxinRes-NESm (C and F); Student’s t test. See also Figure S7.
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on its interaction with GSK-3b.
Axin-b-Catenin Interaction Enhances Neuronal
Differentiation
Next, we investigated how nuclear Axin promotes neuronal
differentiation. Axin was progressively enriched in the nuclei of
NPCs upon neuronal differentiation (Figures 3C and 7A). The
neuronal differentiation of progenitors was marked by the
prominent upregulation of proneural target genes of b-catenin
(including Ngn1 and NeuroD1) (Hirabayashi et al., 2004; Kuwa-
bara et al., 2009) together with reduced levels of antineural
b-catenin targets (e.g., Cyclin D1 and N-myc) (Clevers, 2006;
Kuwahara et al., 2010) (Figure S7A). Axin interacted with b-cate-674 Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc.nin in the nuclear compartments of differentiating NPCs
(Figure 7A). Although the nuclear accumulation of b-catenin is
important for its transcriptional activity, the nuclear accumula-
tion of Axin and hence its interaction with b-catenin were not
prerequisites for the nuclear localization of b-catenin; this is
because Axin level was significantly reduced (Figure 4B),
whereas b-catenin level remained unchanged (Figures S7B
and S7C), in the nuclei of cdk5/ cells. Nonetheless, the interac-
tion between Axin and b-catenin was critical for nuclear Axin to
enhance b-catenin transcriptional activity in the NPCs of the
mouse neocortex (Figures 7B, 7C, S7D, and S7E), as indicated
by the TOP-dGFP reporter assay (Zhang et al., 2010b). Axin
overexpression in NPC nuclei increased the levels of proneural
targets of b-catenin, Ngn1 and NeuroD1, by 4.3 ± 0.3-fold and
Figure 8. Subcellular Axin Localization
Determines the Amplification and Neuronal
Differentiation of NPCs during Embryonic
Neurogenesis via the Activation of Specific
Signaling Networks in NPCs
(A) Axin in the cytoplasm of RGsmaintains RG self-
renewal and promotes IP generation through its
interaction with GSK-3b.
(B) Upon development, Axin is phosphorylated at
Thr485 and becomes enriched in the nuclei of
NPCs, particularly IPs, triggering neuronal differ-
entiation through binding to b-catenin.
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Axin Is a Key Molecular Control of Neurogenesis0.7 ± 0.2-fold, respectively (Figure 7D). Intriguingly, blocking the
interaction between nuclear Axin and b-catenin by expressing
the Axin point mutant (CIDm) that was unable to bind b-catenin
in the nucleus (Xing et al., 2003) inhibited neuronal differentiation
and maintained the NPC pool (Figures 7E and 7F), particularly
IPs (Figures S7F and S7G). To further confirm the importance
of the interaction between Axin and b-catenin in the nucleus,
we designed a small peptide CID based on the protein sequence
of the b-catenin-interacting domain of Axin (Xing et al., 2003) and
tagged the peptide with an SV40 T-antigen NLS to enable spe-
cific targeting of the CID peptide into the nucleus. CID-NLS
effectively blocked the interaction between Axin and b-catenin
(Figure S7H) and significantly inhibited neuronal differentiation
in themouse neocortex (Figures 7G and 7H). These observations
collectively indicate that nuclear Axin promotes neuronal differ-
entiation in a b-catenin-dependent manner.
DISCUSSION
The fate decision of NPCs between amplification and differenti-
ation controls the number of neurons produced during brain
development and ultimately determines brain size. However, it
is unclear how the NPCs make this fundamental choice. Here,
we show that the subcellular localization of a signaling scaf-
fold protein, Axin, defines the activation of specific signaling
networks in NPCs, thereby determining the amplification or
neuronal differentiation of NPCs during embryonic development
(Figure 8). Cytoplasmic Axin in NPCs enhances IP generation,
which ultimately leads to increased neuron production, whereas
nuclear Axin in IPs promotes neuronal differentiation. Intrigu-
ingly, the Cdk5-dependent phosphorylation of Axin facilitates
the nuclear accumulation of the protein, thereby functioning as
a ‘‘brake’’ to prevent the overproduction of IPs and induce
neuronal differentiation.Neuron 79, 665–679Axin Governs the Expansion of the
Mammalian Cerebral Cortex
through IP Pool Amplification
The drastic increase in the size of the
cerebral cortex in the human brain, which
is thought to underpin our unique higher-
cognitive functions, is associated with a
disproportionate expansion of cortical
neurons, especially the upper-layer neu-
rons. The expansion of cortical surfacemay result from increased numbers of neuroepithelial (NE) cells
and RGs (Rakic, 2009) or from an amplified IP pool (Pontious
et al., 2008). NE/RG augmentation evidently controls the global
enlargement of cortical surface (Chenn and Walsh, 2002; Vac-
carino et al., 1999). The amplification of a subset of RGs express-
ing the transcription factor Cux2 was recently suggested to
facilitate upper-layer neuron expansion (Franco et al., 2012).
However, there is a lack of experimental evidence indicating
whether IP amplification also substantially contributes to the
expansion of upper-layer cortical neurons and the cerebral
cortex. Nonetheless, upper-layer neurons are generated during
mid- and late neurogenesis (Molyneaux et al., 2007), at which
time IPs play the primary role in neuron production. Moreover,
the enlargement of IP-residing SVZ is temporally correlated
with the increased number of upper-layer neurons and expanded
cortical surface (Zecevic et al., 2005). Therefore, it is tempting to
speculate that the amplification of IPs during mid- and late
corticogenesis has facilitated the evolutionary expansion of the
cerebral cortex. Our present findings demonstrate that in-
creasing Axin levels during midcorticogenesis, which leads to
the transient amplification of IPs without affecting the RG pool,
is sufficient to expand the surface of the neocortex (Figures 1
and 2). Previous studies show that Axin expression is tightly regu-
lated by different posttranslational modifications including deu-
biquitination (Lui et al., 2011), SUMOylation (Kim et al., 2008),
methylation (Cha et al., 2011), and phosphorylation (Yamamoto
et al., 1999), which increase the stability of Axin;meanwhile, poly-
ubiquitination (Kim and Jho, 2010) and poly-ADP-ribosylation
(Huang et al., 2009) lead to its degradation. Thus, the adaptive
evolution of the Axin gene that regulates its posttranslational
modifications and hence its expression level might be involved
in the evolutionary expansion of the cerebral cortex.
To ensure the development of a cerebral cortex of the proper
size, the amplification and neuronal differentiation of IPs need to, August 21, 2013 ª2013 Elsevier Inc. 675
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cious depletion of NEs/RGs (Buchman et al., 2010) or inhibition
of IP generation/proliferation (Sessa et al., 2008) ultimately lead
to the generation of fewer cortical neurons, resulting in a smaller
cortex—a characteristic feature of human microcephalic syn-
dromes. In contrast, the overexpansion of IPs (Lange et al.,
2009) generates an excessive number of neurons, which is asso-
ciated with macrocephaly and autism (McCaffery and Deutsch,
2005).Our findingsdemonstrate that Axin strictly controls thepro-
cess of indirect neurogenesis to ensure the production of a proper
number of neurons. Although cytoplasmic Axin simultaneously
maintains the RG pool and promotes IP amplification to sustain
rapidand long-lastingneuronproduction, subsequentenrichment
of Axin in the nuclei of IP daughter cells triggers neuronal differen-
tiation and prevents the overexpansion of IPs. In addition, the re-
sults demonstrate thatCdk5-mediatedphosphorylation regulates
the nucleocytoplasmic shuttling of Axin, thereby controlling the
switching of NPCs from proliferative to differentiation status.
Axin Phosphorylation Triggers the Differentiation of IPs
into Neurons
Our findings show that Axin phosphorylation in IPs triggers
neuronal differentiation in a rostrolateral-high to caudomedial-
low gradient correlated with the spatial gradient of neurogenesis
(Figures 4 and 5) (Caviness et al., 2009). Thus, the gradient of Axin
phosphorylationmayprovide aquantitative tool for evaluating the
temporal and spatial gradient of IP differentiation into neurons.
Importantly, nuclear Axin phosphorylation is rapidly induced in
IP daughter cells in the G1 phase, which is the stage when pro-
genitor cells actively respond to neurogenic signals (Dehay and
Kennedy, 2007); this suggests that the timing of Axin phosphory-
lation-dependent IP differentiation is regulated by diffusible
extracellular signals (Tiberi et al., 2012). Therefore, understanding
howAxin phosphorylation is regulated in IPsby extracellular cues
and niches should shed new light on the molecular basis under-
lying the gradient-specific differentiation of IPs.
Our findings also highlight the importance of Cdk5 in embry-
onic neurogenesis. Although Cdk5 plays critical roles in neuronal
development (Jessberger et al., 2009) and is implicated in the
neurogenesis of cultured neural stem cells (Zheng et al., 2010),
it remains unclear whether Cdk5 regulates embryonic neurogen-
esis. Our findings provide in vivo evidence that Cdk5 is required
for the neuronal differentiation of IPs, at least in part through
phosphorylating Axin. Intriguingly, although cdk5/ cortices
exhibited an accumulation of IPs and reduced neuron produc-
tion during early-mid neurogenesis (Figure 4), the brain size of
thesemutantmice remained unchanged by the end of neurogen-
esis (Dhavan and Tsai, 2001). This may be due to the compensa-
tory increase of neuron production from the expanded pool of
IPs during themid-to-late neurogenesis stages. Therefore, eluci-
dating how Cdk5 is involved in different stages of neurogenesis
may provide insights into the molecular control of neuronal num-
ber and subtypes.
Subcellular Axin Signaling Coordinates the Generation,
Amplification, and Differentiation of IPs
Several factors that regulate the generation and amplification of
IPs have been identified (Pontious et al., 2008). Nonetheless, key676 Neuron 79, 665–679, August 21, 2013 ª2013 Elsevier Inc.questions remain open: how RGs determine to differentiate into
IPs instead of neurons, how RG-to-IP transition and IP differen-
tiation are coordinated, and how IP amplification and differenti-
ation are balanced. The present results show that the interaction
between cytoplasmic Axin and GSK-3b maintains the RG pool
and promotes IP production (Figure 6). The signaling mecha-
nisms underlying the action of Axin-GSK-3b interaction require
further investigation. We hypothesize that Axin regulates IP dif-
ferentiation from RGs via various molecular mechanisms. First,
the Axin-GSK-3b complex may reduce the level of Notch recep-
tor or b-catenin (Mun˜oz-Descalzo et al., 2011; Nakamura et al.,
1998), leading to the suppression of Notch- and Wnt-mediated
signaling, respectively (Gulacsi and Anderson, 2008; Mizutani
et al., 2007; Woodhead et al., 2006). Given that Axin and
GSK-3b can associate with the centrosome (Fumoto et al.,
2009; Wakefield et al., 2003) and mitotic spindle (Izumi et al.,
2008; Kim et al., 2009a), Axin-GSK-3b interaction may also
modulate cleavage plane orientation (Postiglione et al., 2011).
Furthermore, Axin-GSK-3b can interact with and affect the
microtubule-binding activity of adenomatous polyposis coli
(APC) (Nakamura et al., 1998), which is required for establishing
the apical-basal polarity and asymmetric division of RGs (Yokota
et al., 2009). Finally, interaction with Axin can cause GSK-3b
inhibition (Fang et al., 2011), which may enhance IP amplification
(Kim et al., 2009b) through the activation of Shh signaling
(Komada et al., 2008).
The timing of IPs to undergo cell-cycle exit balances the pro-
liferative and neurogenic divisions of IPs and switches the RG-
to-IP transition to the neuronal differentiation of IPs. We show
that the interaction between Axin and b-catenin in the nucleus
switches the division of IPs from proliferative to neurogenic by
enhancing the neurogenic transcriptional activity of b-catenin
(Figure 7). Indeed, Axin and b-catenin are required for the signal
transduction of Wnt (Hirabayashi et al., 2004; Munji et al., 2011),
RA (Otero et al., 2004), and TGF-b (Zhang et al., 2010a), which
triggers and promotes neuronal differentiation. Thus, Axin in
the nucleus may serve to transduce and converge multiple
neurogenic signaling pathways to b-catenin during neurogene-
sis. However, the mechanism by which nuclear Axin enhances
the transcriptional activity of b-catenin requires further investiga-
tion. Given that b-catenin exerts its transcriptional regulation of
target genes through association with T cell factor/lymphoid
enhancer factor (Tcf/Lef), we hypothesize that nuclear Axin
facilitates b-catenin/Tcf/Lef complex formation to enhance
transcription (Shitashige et al., 2008).
Although Axin was previously recognized as a negative regu-
lator of canonical Wnt signaling, suppressing cell division by
recruiting GSK-3b and b-catenin into the b-catenin destruction
complex for b-catenin degradation (Ikeda et al., 1998), the pre-
sent results show that cytoplasmic Axin and nuclear Axin act
distinctly from canonical Wnt signaling through specific binding
to GSK-3b and b-catenin, respectively. Therefore, our findings
corroborate the notion that Wnt signaling components play
multifaceted roles in NPCs during neurogenesis independent
of canonical Wnt signaling as demonstrated in previous studies
(Kim et al., 2009b; Yokota et al., 2009).
In conclusion, the present study identified distinct roles of
Axin in IP amplification and neuron production. Our results
Neuron
Axin Is a Key Molecular Control of Neurogenesisdemonstrate that themodulation of Axin levels, subcellular local-
ization, phosphorylation, and its interaction with key signaling
regulators (e.g., GSK-3b and b-catenin) in NPCs ultimately con-
trol neuron production and expansion of the cerebral cortex.
Given that Axin is a key regulator of the switch from IP amplifica-
tion to differentiation, the characterization of the signals that
control this switch will not only advance our current understand-
ing of how the cerebral cortex expands during evolution but also
provide important insights into neurodevelopmental disorders
such as microcephaly.
EXPERIMENTAL PROCEDURES
Procedures regarding shRNA, expression constructs, chemicals, reagents,
antibodies, mice, NPC culture, pair-cell analysis, in vivo b-catenin transcrip-
tional activity assay, image acquisition, and quantitative analysis can be found
in the Supplemental Experimental Procedures. All animal procedures were
conducted in accordance with the Guidelines of the Animal Care Facility of
the Hong Kong University of Science and Technology (HKUST) and were
approved by the Animal Ethics Committee in HKUST.
Intraventricular Microinjection
The embryos of timed-pregnant ICR mice at E13.5 were anesthetized with
pentobarbital (5 mg 3 ml1) and exposed and transilluminated to visualize
the cerebral ventricles (Fang et al., 2011). XAV939 (1 mM) was microinjected
into the lateral ventricles. After 2 hr or at E14.5, the pregnant mice were
intraperitoneally injected with one pulse of the nucleoside analog, EdU
(30 mg 3 kg1). The injected fetuses were harvested at E15.5 or E17.5, intra-
cardially perfused with 4% paraformaldehyde (PFA), and subjected to EdU
staining. At least six brains were analyzed for each condition.
In Utero Electroporation and Transfection
In utero electroporation of embryos at E12.5 or E13.5 was performed as
described previously (Fang et al., 2011). At least three independent experi-
ments were performed, and at least six brains were analyzed for each con-
dition. The final concentration of plasmids used for each condition can be
found in the Supplemental Experimental Procedures. Mouse embryonic
NPCs were transfected using the Amaxa Nucleofector Kit (Lonza) follow-
ing the Amaxa optimized protocol (program: A033) for mouse neural stem
cells.
In Utero EdU Labeling
To examine cell-cycle exit, EdU was injected into pregnant mice 24 hr after
electroporation. Twenty-four hours after injection, the brains were pro-
cessed, and EdU was detected using the Click-iT EdU Alexa Fluor Imaging
Kit (Invitrogen). To correlate the regulation of phospho-Axin with cell phase
distribution, EdU (30 mg 3 kg1) was intraperitoneally injected into pregnant
ICR mice at E15.5. The cell cycle in E15.5 mice is 18 hr long, comprising an
12 hr G1 phase, 4 hr S phase, and 2 hr G2/M phase. To label the S and
G2 phases of NPCs, E15.5 embryos were subjected to two pulses of EdU,
2 and 0.5 hr prior to harvesting, respectively. To label the late G1 phase
progenitors, the embryos were collected 14 hr after EdU injection (Britz
et al., 2006).
Western Blot, Nuclear Coimmunoprecipitation, and
Immunohistochemical Analyses
Western blotting, immunoprecipitation, and immunohistochemistry were per-
formed as described previously (Fang et al., 2011). Cytosolic and nuclear frac-
tionation was performed using the Nuclear/Cytosol Extraction Kit (BioVision).
Nuclear coimmunoprecipitation was carried out using the Nuclear Complex
Co-IP Kit (Active Motif).
Statistical Analysis
Statistical analyses were performed with Student’s t test using GraphPad
Prism (GraphPad Software). All bar graphs represent mean ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2013.06.017.
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